Monocyte Chemotactic Protein-1 Regulates Proliferation and Contractility of Human Bladder Smooth Muscle Cells Under Hydrostatic Pressure

单核细胞趋化蛋白-1 调节静水压力下人膀胱平滑肌细胞的增殖和收缩力

阅读:5
作者:Guo Chen, Xi Jin, Xiaoshuai Gao, Jianzhong Ai, Deyi Luo, Liang Zhou, Kaiwen Xiao, Zirui Li, Hong Li, Kunjie Wang

Abstract

Bladder growth and development require continuous mechanical stimuli; however, abnormal mechanical conditions caused by partial bladder outlet obstruction (PBOO) result in detrusor smooth muscle hypertrophy and extracellular matrix accumulation. Our previous study demonstrated that PBOO induced an increase in monocyte chemotactic protein-1 (MCP-1) expression. To extensively illustrate whether and how MCP-1 participates in the remodeling of PBOO, we assess the pivotal effect of MCP-1 and its specific receptor chemokine (C-C motif) receptor 2 (CCR2) on the proliferation and contraction of human bladder smooth muscle cells (hBSMCs) under pathological hydrostatic pressure (HP). HP markedly promoted hBSMC proliferation and enhanced cell contraction along with the increase in MCP-1 expression. Recombinant human MCP-1 (rhMCP-1) enhanced HP-induced hBSMC proliferation and contraction. CCR2 antagonists and MCP-1 silencing reversed HP-induced proliferation and contraction. In addition, MCP-1-induced protein 1 (MCPIP1) silencing attenuated the contraction, but not the proliferation, induced by HP, whereas serum-glucocorticoid regulated kinase 1 (SGK1) silencing prevented the rhMCP-1-induced proliferation of hBSMCs under HP. Decrease of reactive oxygen species (ROS) level downregulated MCP-1 expression; in turn, rhMCP-1 promoted the generation of ROS. In conclusion, we demonstrated that pathological HP-promoted hBSMC proliferation was mainly regulated by the MCP-1/CCR2- SGK1 pathway and hBSMCs contraction was mainly moderated by the MCP-1/CCR2 -MCPIP1 pathway. [Figure: see text].

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。